Frequently Asked Questions Is compounded semaglutide legal right now
What published clinical research shows: The STEP-1 trial (semaglutide, published in NEJM 2021) demonstrated that participants with obesity or overweight without diabetes who received semaglutide 2.4 mg weekly plus lifestyle intervention experienced mean weight loss of 14.9% over 68 weeks
Even though research on this peptide is still in its early stages, results suggest that it supports tissue repair, reduces inflammation, and promotes overall recovery
Michael Snyder, an obesity specialist, emphasized that dehydration can worsen gastrointestinal side effects
Injections are made with thin needles into one of these areas of the body
What Ive seen in my practice In my practice, Ive often seen patients return to their baseline weight within two years of treatment